Imaging-based prognosis check for spinal tumors treated with SBRT
Part of Brain & nervous system, Cancer clinical trials.
This trial studies whether special CT/MRI/PET-CT image patterns (called radiomics) can predict how well spinal tumor patients do after stereotactic radiosurgery (SBRT). If you’re having SBRT, your scans before and after treatment may be used to better estimate outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a spinal tumor where SBRT is an appropriate treatment
- Your ability to do daily activities is fairly good (Karnofsky score over 60)
- You’re expected to live at least 3 months
- You can safely have MRI (no severe claustrophobia and no non-MRI-safe devices/materials)
- You will get CT/MRI/PET-CT scans before and after treatment and agree to SBRT
- You are not pregnant and not breastfeeding, and you don’t have an allergy to the MRI contrast dye
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise type of radiation (stereotactic radiotherapy) for spinal tumors or cancer that has spread to the spine. It aims to study how best to target the radiation to improve treatment while reducing side effects.
This trial tests whether giving focused radiation before surgery can improve treatment for spinal tumors that have spread from other cancers. It may help people who need surgery for a spinal tumor and have a life expectancy of more than 6 months.
This trial tests a special type of proton radiation for people whose spine cancer has spread from another part of the body and cannot be treated effectively with standard X-ray radiation. The goal is to see if proton radiation can safely deliver a high dose of radiation to the tumor.
This study tests whether radiation given after limited surgery helps control cancer that has spread to a small area of the spine. It may help reduce tumor growth in the treated spine area and improve local control after operation.
This early (Phase 1) study uses a special PET scan to measure how your immune system responds after stereotactic body radiation therapy (SBRT). The goal is to see whether the scan result can serve as a marker of immune response, which may help future treatment planning.
This trial uses a special PET scan to see how well stereotactic radiotherapy works for brain metastases. You may join if you have at least one brain tumor that your doctor thinks should be treated with this precise type of radiation.
Hear when a new Spinal Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.